Krystal Biotech KRYS
NASDAQ KRYS
$333.01 -2.05 (-0.61%)
As of: Sep 30, 2026 · 3:59 PM EDT

Krystal Biotech (KRYS) Capital Expenditures (2016 - 2026)

Updated

Krystal Biotech (KRYS) posted Capital Expenditures of $3.57 million for Q2 2026, up 87.2% from $1.9 million a year earlier but down 50.1% from the prior quarter.

Analysis

Krystal Biotech (KRYS) Capital Expenditures (2016 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Krystal Biotech was $14.56 million, up 46.2% year-over-year; for FY2025, it came in at $11.95 million, up 182.0% from FY2024.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of -4.2% (FY2020 to FY2025).
  • In prior years, Krystal Biotech's Capital Expenditures was $4.24 million in FY2024 (-64.1%), $11.8 million in FY2023 (-77.7%), $52.98 million in FY2022 (-22.5%) and $68.34 million in FY2021 (+360.4%).
  • Quarterly Capital Expenditures has run from a low of $801,000 in Q4 2024 to a high of $40.88 million in Q4 2021 over five years.
  • On a year-over-year basis, Capital Expenditures has increased in each of the last six quarters, with growth averaging 86.9% over the last eight quarters.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2022, with growth of 595.1%; the weakest was Q3 2023, with a decline of 87.3%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $7.15 million (Q1 2026), $2.14 million (Q4 2025) and $1.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Krystal Biotech 9.92 Bn 6.69 Bn 112.79 Mn 3.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.57 Mn
Mar 31, 2026 7.15 Mn
Dec 31, 2025 2.14 Mn
Sep 30, 2025 1.70 Mn
Jun 30, 2025 1.90 Mn
Mar 31, 2025 6.20 Mn
Dec 31, 2024 801,000.00
Sep 30, 2024 1.05 Mn
Jun 30, 2024 1.13 Mn
Mar 31, 2024 1.26 Mn
Dec 31, 2023 1.85 Mn
Sep 30, 2023 1.78 Mn
Jun 30, 2023 2.79 Mn
Mar 31, 2023 5.38 Mn
Dec 31, 2022 5.22 Mn
Sep 30, 2022 14.06 Mn
Jun 30, 2022 16.52 Mn
Mar 31, 2022 17.19 Mn
Dec 31, 2021 40.88 Mn
Sep 30, 2021 20.99 Mn
API Access

Krystal Biotech Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=KRYS&period=max&api_key=YOUR_API_KEY